Updates in targeted therapy for melanoma

Education, collaboration and communication in global cancer control

Health related quality of life findings from COMBI-AD

Developing a survivin vaccine for glioblastoma

Early results from a 3rd gen EGFR-TKI in advanced NSCLC

New pathways in pancreatic cancer

OPTIMISMM trial for refractory multiple myeloma

Treatment updates in Merkel cell carcinoma

Results from the LILAC study of ABP 980 with trastuzumab for HER2 early breast cancer

New treatment markers for myeloma

Most breast cancer patients could avoid chemo with use of genetic testing

Pembrolizumab works better than chemotherapy alone as initial treatment for NSCLC